- Latest available (Revised)
- Original (As adopted by EU)
Commission Implementing Regulation (EU) 2018/84 of 19 January 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances chlorpyrifos, chlorpyrifos-methyl, clothianidin, copper compounds, dimoxystrobin, mancozeb, mecoprop-p, metiram, oxamyl, pethoxamid, propiconazole, propineb, propyzamide, pyraclostrobin and zoxamide (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This is the original version as it was originally adopted in the EU.
This legislation may since have been updated - see the latest available (revised) version
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 54, Propineb, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 55, Propyzamide, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 58, Propiconazole, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 77, Zoxamide, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 111, Chlorpyrifos, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 112, Chlorpyrifos-methyl, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 114, Mancozeb, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 121, Clothianidin, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 122, Pethoxamid, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 277, Copper compounds, the date is replaced by ‘31 January 2019’.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: